VX-770

ivacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VX-770, covering 2010-01-05 to 2022-02-17. Get the full timeline:

Most recent: Clinical Trial Update: VX-770 for the Treatment of Chronic Bronchitis [Phase 4]